Company Information

    Editas Medicine was founded on January 2013. The company is based in Cambridge, MA, USA . The number of employees in Editas Medicine is less than 250. Editas medicine is engaged in discovering and developing a novel class of genome editing therapeutics.

    Here is how Editas Medicine describes itself: "Editas Medicine is a leading gene editing company focused on developing CRISPR medicines for people with serious diseases."
      If you are the founder or part of the founding team, please tell the world your story


          Funding & investors

          Editas Medicine has received 4 rounds of venture funding. The total funding amount is around $656.6M. Last venture funding round was $231M, announced on January, 2021.

            Similar Companies [beta]

              Venture Categories

                Active Venture Investors




                  Venture Competitors

                    News

                        Editas Medicine - Blog


                          Share:     facebook    twitter    linkedin    reddit    email

                            Ventures Media is one of the largest startup and venture capital communities for startup and venture capital funding information and analysis.

                            Leave a Reply

                            Your email address will not be published. Required fields are marked *